SMTL ID : 7teu.1

Crystal structure of JAK2 JH1 with type II inhibitor YLIU-04-105-1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

1 x I6C: 3-{(4S)-2-[(cyclopropanecarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}-N-{3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-4-methylbenzamide(Non-covalent)

I6C.1: 24 residues within 4Å: Chain A: L.40, V.48, A.65, K.67, E.83, L.87, L.90, I.95, V.96, L.112, M.114, E.115, Y.116, L.117, P.118, G.120, Y.157, H.159, D.161, L.168, I.177, G.178, D.179, F.180 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:L.40, A:V.48, A:A.65, A:K.67, A:K.67, A:E.83, A:L.87, A:L.112, A:M.114, A:Y.116, A:L.168, A:D.179 Hydrogen bonds: A:E.83, A:E.83, A:L.117, A:L.117, A:D.179 Salt bridges: A:E.83, A:D.179, A:D.179

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: D.161, R.165, N.166, D.179, F.180, G.181 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:D.161, A:R.165, A:R.165, A:N.166, A:G.181 Water bridges: A:D.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arwood, M.L. et al., New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell Chem Biol (2023)

Release Date

2023-06-21

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2